Avectas Ltd
Avectas is accelerating the future of cell therapy with a flexible manufacturing platform, Solupore, that engineers healthier and more functional cells for patients. Avectas has developed an optimized non-viral transfection process aligned with GMP manufacturing and is integrating further processes to support cell therapy manufacturing workflows. Key applications are in CAR-T cell manufacturing. reprogramming of blood cells to IPS cells and editing of IPS cells.
Avectas is a private, international company with research facilities in Dublin and an office in Cambridge MA, USA. It has 33 employees and is led by a team of highly experienced pharmaceutical executives, and supported by a world-class Scientific Advisory Board of cancer cell therapy experts.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}